1 / 8

Design of soluble epoxide hydrolase inhibitors as drug leads

Design of soluble epoxide hydrolase inhibitors as drug leads. Junghwa Kim, Elise Pellmann, Mike Wild Daniel Sem, Ph.D. John Imig, Ph.D. sEH: biology. Epoxyeicosatrienoic acids (EETs) Cytochrome P450 Vasodilation, anti-inflammatory, angiogenesis. sEH inhibition. sEH: biochemistry.

ace
Download Presentation

Design of soluble epoxide hydrolase inhibitors as drug leads

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Design of soluble epoxide hydrolase inhibitors as drug leads Junghwa Kim, Elise Pellmann, Mike Wild Daniel Sem, Ph.D. John Imig, Ph.D.

  2. sEH: biology • Epoxyeicosatrienoic acids (EETs) • Cytochrome P450 • Vasodilation, anti-inflammatory, angiogenesis • sEH inhibition

  3. sEH: biochemistry Two domains: hydrolase (N-terminal), phosphatase (C-terminal)

  4. sEH As a Teaching ExampleHydrolysis of Epoxides, Enzyme Activity, Catalytic Triad

  5. Imig Group Experiment • Development of EET Analogs • Studied Male Rats • Renal Effects • Blood Pressure/Heart Rate • Most Promising Lead- 11,12-ether-EET-8-ZE

  6. Inhibitor Design • Study of 1VJ5 Crystal Structure • Jmol and Swiss Viewer • Propose Drug Leads • Draw in ChemDraw From Swiss Viewer

  7. Inhibitor Design • Draw Structure of Drugs in Spartan • Place designed drugs on Enzyme (sEH) through Discovery Studio Visualizer

  8. What’s next? • Kinetic assays (in vitro): Determine Kd, mode of inhibition • ADMET (in vivo, in silico) In silico: docking, TOPKAT (accelrys)

More Related